New global cancer hub to be developed
4 Feb 2016 by Evoluted New Media
A leading resource for cancer research and treatment is to be built in Sutton, London, with the aim of delivering at least two extra cancer drugs every five years.
A leading resource for cancer research and treatment is to be built in Sutton, London, with the aim of delivering at least two extra cancer drugs every five years.
The London Cancer Hub is a partnership between the Institute of Cancer Research (ICR), The Royal Marsden NHS Foundation Trust and the London Borough of Sutton.
Professor Paul Workman, chief executive of the ICR, said: “This is an exciting project to create the world’s leading cancer research campus here in London. The ambition is to discover more innovative cancer drugs, to run more clinical trials, and to partner with industry to take even more treatments to patients.”
The Cancer Hub, which will cover 265,000 sq m, will bring together 10,000 scientists and clinical staff to be a ‘hotbed’ of talent, with R & D space for biotech, pharma and software companies as well as equipment manufacturers.
Boris Johnson, Mayor of London, said: “London is already a global capital of science and is awash with numerous exciting research institutions. The London Cancer Hub would be a real coup for the city and would help to ensure that the capital remains on the frontline of developing new treatments to cure the disease."
The Hub will be financed through a mixture of government grants, commercial rent income and private investment.
The public will be consulted with a ‘masterplan’ for the site and surrounding area later on this month. It forms part of Sutton Council’s 15 year plan for the county. Enhancing the existing tram system extending it to Sutton, building a secondary school near the centre form part of the proposal also.
